⚡ZurzAI.com⚡

Niramai Health Analytix is a Bangalore-based deep-tech startup specializing in innovative health solutions, particularly for early detection of breast cancer. They focus on creating automated technologies that are non-invasive, affordable, and widely accessible. Below is a summary of their offerings and unique features:

Technology: Thermalytix

• Thermalytix is their flagship AI-based breast cancer screening test. This technology detects breast abnormalities using a high-resolution thermal sensing device combined with machine learning and deep learning algorithms.
• Key Features:
  • Non-Invasive and Privacy-Sensitive: It offers a contactless, radiation-free, and painless screening process, maintaining patient privacy as nobody sees or touches the patient during the test.
  • Portable and Low Cost: The technology is portable, allowing screenings to be conducted in various settings, and is cost-effective compared to traditional methods.
  • High Accuracy: It can detect much smaller tumors (5mm) than physical examinations (25mm) and is particularly effective in screening younger women with dense breast tissues.
  • Global Reach: Thermalytix is available in multiple countries, including India, UAE, Kenya, Sweden, Turkey, and the Philippines, and has received regulatory approvals in these regions.

Products and Services

• Niramai SMILE-100: A subset of the Thermalytix system cleared by the US FDA for thermal breast imaging, used as diagnostic adjunct imaging.
• Home and Hospital Screenings: Offers both in-home and hospital breast cancer screenings, ensuring maximum convenience and privacy.
• Gift Coupons and Corporate Partnerships: Allows individuals to gift screening services and enables organizations to set up health camps, reaching underserved communities.

Achievements and Recognition

• Niramai has conducted over 250,000 screenings globally, with installations in more than 150 facilities across various countries.
• Patents and Approvals: Holds 35 multinational patents and complies with quality and regulatory standards like ISO 13485 and CE Mark.
• Awards: Recognized as an innovative startup, receiving accolades like the Rising Star Award by Startus Insights and European CE Mark Approval.

Collaborations

• Molbio Diagnostics Partnership: This collaboration aims to expand the reach of Thermalytix in both public and private healthcare markets globally.
• Action Pink Initiative: A joint effort with the German NGO to enhance global breast cancer awareness and early detection strategies.

Clinical Studies and Publications

• Niramai’s Thermalytix has been the focus of numerous clinical studies published in top medical journals. Findings indicate its high accuracy and comparative advantages over traditional mammography, especially in detecting breast cancer among women with dense breasts.

Mission

• Niramai is committed to revolutionizing cancer screening methods through innovative, technology-driven solutions designed to save lives by enabling early detection and treatment.

Overall, Niramai Health Analytix leverages cutting-edge AI technology to provide a sophisticated, patient-friendly method for breast cancer screening that can be scaled globally, in line with their mission to create a universal cancer screening method.